Neuphoria Therapeutics Inc. - NEUP
Detailed investor-level table based on 13F positions.
Early Q1 2026 data: only 1 institutional holders reported so far. The full shareholder list will grow as more funds file with the SEC.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | History | New | 875,228 | 3,395 | 0.69% | — | 1 | +875,228 | New | Q4 2025 | Feb 17, 2026 |
| Shay Capital LLC | History | New | 169,059 | 655 | 0.07% | — | 2 | +169,059 | New | Q4 2025 | Feb 17, 2026 |
| AdvisorShares Investments LLC | History | Added to | 134,194 | 520 | 0.09% | 0.11% | 3 | +75,631 | 129.14% | Q4 2025 | Feb 10, 2026 |
| DIADEMA PARTNERS LP | History | Added to | 50,000 | 194 | 0.03% | 0.06% | 4 | +28,548 | 133.08% | Q4 2025 | Feb 17, 2026 |
| Ikarian Capital, LLC | History | New | 47,443 | 184 | 0.01% | — | 5 | +47,443 | New | Q4 2025 | Feb 18, 2026 |
| ADAR1 Capital Management, LLC | History | New | 30,000 | 116 | 0.01% | — | 6 | +30,000 | New | Q4 2025 | Feb 18, 2026 |
| FNY Investment Advisers, LLC | History | New | 26,500 | 102 | 0.03% | — | 7 | +26,500 | New | Q4 2025 | Jan 16, 2026 |
| VANGUARD GROUP INC | History | No change | 20,950 | 81 | 0.0% | 0.0% | 8 | 0 | 0.0% | Q4 2025 | Jan 29, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | History | Added to | 17,303 | 67 | 0.0% | 0.0% | 9 | +4,325 | 33.33% | Q4 2025 | Feb 09, 2026 |
| JANE STREET GROUP, LLC | History | Added to | 16,597 | 64 | 0.0% | 0.0% | 10 | +928 | 5.92% | Q4 2025 | Feb 12, 2026 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | History | New | 14,750 | 57 | 0.0% | — | 11 | +14,750 | New | Q4 2025 | Feb 17, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | History | New | 14,000 | 54 | 0.0% | — | 12 | +14,000 | New | Q4 2025 | Feb 17, 2026 |
| Persistent Asset Partners Ltd | History | Added to | 13,403 | 52 | 0.02% | 0.04% | 13 | +8,495 | 173.08% | Q4 2025 | Feb 17, 2026 |
| XTX Topco Ltd | History | New | 12,008 | 46 | 0.0% | — | 14 | +12,008 | New | Q4 2025 | Feb 17, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | History | New | 11,207 | 43 | 0.0% | — | 15 | +11,207 | New | Q4 2025 | Feb 12, 2026 |
| Merck & Co., Inc. | History | No change | 10,027 | 38 | 0.01% | 0.05% | 16 | 0 | 0.0% | Q4 2025 | Feb 17, 2026 |
| UBS Group AG | History | Reduced | 1,652 | 6 | 0.0% | 0.0% | 17 | -516 | -23.8% | Q4 2025 | Jan 29, 2026 |
| Tower Research Capital LLC (TRC) | History | Added to | 1,400 | 5 | 0.0% | 0.0% | 18 | +990 | 241.46% | Q4 2025 | Feb 17, 2026 |
| MILLENNIUM MANAGEMENT LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -18,329 | -100.0% | Q3 2025 | Nov 14, 2025 |
| RHUMBLINE ADVISERS | History | Added to | 202 | 0 | — | — | — | +169 | 512.12% | Q4 2025 | Feb 13, 2026 |
| MORGAN STANLEY | History | Added to | 58 | 0 | — | — | — | +51 | 728.57% | Q4 2025 | Feb 13, 2026 |
| FMR LLC | History | Closed out | 0 | 0 | — | — | — | -2 | -100.0% | Q3 2025 | Nov 13, 2025 |
| BANK OF AMERICA CORP /DE/ | History | Added to | 18 | 0 | — | — | — | +1 | 5.88% | Q4 2025 | Feb 17, 2026 |